Floxuridine 81643-9270-01
- Manufacturer
- Jnd Therapeutics, Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intra-Arterial
- Product Type
- Human Prescription Drug
- Marketing Start
- June 9, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA075387
Need to source Floxuridine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Floxuridine | 500 mg/1 |
Drug Class
Antimetabolite [EPC]Antimetabolite [EPC]Deoxyuridine [CS]
Selected Package
81643-9270-01Selected1 VIAL in 1 BOX, UNIT-DOSE (81643-9270-1) / 5 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL